enGene Therapeutics Inc. (ENGNW)
Biological Products, (No Diagnostic Substances)
Latest Price
$0.23
TTM P/E
0.85
Normalized P/E
0.01
Div Yield
--
Book Value
3.30
P/B Ratio
0.07
Valuation metrics
adjust assumptions →EPS: $2.29
Book value / share: $3.22
Formula: √(22.5 × EPS × BVPS)
Graham Number
$12.89
+5504% upside
Institutional Ownership
3.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BVF INC/IL | 945.4K | -- | 1.41% | -- | 2026-06-30 |
| Blue Owl Capital Holdings LP | 511.2K | -- | 0.76% | -- | 2026-06-30 |
| Caption Management, LLC | 333.7K | -- | 0.50% | -- | 2026-06-30 |
| LMR Partners LLP | 309.8K | -- | 0.46% | -- | 2026-06-30 |
| ARISTEIA CAPITAL, L.L.C. | 197.7K | -- | 0.29% | -- | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 104.6K | -- | 0.16% | -- | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 69.0K | -- | 0.10% | -- | 2026-06-30 |
| TORONTO DOMINION BANK | 31.5K | -- | 0.05% | -- | 2026-06-30 |
| CSS LLC/IL | 16.9K | -- | 0.03% | -- | 2026-06-30 |
| StoneX Group Inc. | 10.4K | -- | 0.02% | -- | 2026-06-30 |